Clinical presentation and diagnostic delay in pemphigus vulgaris: A prospective study from Turkey

2020 ◽  
Vol 49 (7) ◽  
pp. 681-686
Author(s):  
Özlem Daltaban ◽  
Aslı Özçentik ◽  
Ayşe Akman Karakaş ◽  
Kemal Üstün ◽  
Mükerrem Hatipoğlu ◽  
...  
Keyword(s):  
Prospective Study ◽  
Clinical Presentation ◽  
Diagnostic Delay ◽  
Pemphigus Vulgaris ◽  
A Prospective Study

scholarly journals Neuropathic Pain in Children with Sickle Cell Disease: The Hidden Side of the Vaso-Occlusive Crisis

Children ◽  
2021 ◽  
Vol 8 (2) ◽  
pp. 84
Author(s):  
Jeanne Sigalla ◽  
Nathalie Duparc Alegria ◽  
Enora Le Roux ◽  
Artemis Toumazi ◽  
Anne-Françoise Thiollier ◽  
...  
Keyword(s):  
Risk Factors ◽  
Neuropathic Pain ◽  
Sickle Cell Disease ◽  
Sex Ratio ◽  
Prospective Study ◽  
Sickle Cell ◽  
Clinical Presentation ◽  
Early Stage ◽  
Cell Disease ◽  
A Prospective Study

The majority of hospitalizations of patients with sickle cell disease (SCD) are related to painful vaso-occlusive crises (VOCs). Although the pain of VOC is classically nociceptive, neuropathic pain (NP) has also been demonstrated in SCD patients. The aim of our study is to specify the prevalence of NP during VOCs in SCD children using a dedicated scale and to measure its characteristics. We performed a prospective study that included SCD children hospitalized for an acute VOC. The presence of NP was sought with the DN4 scale on the second and fourth days of hospitalization. A total of 54 SCD children were included in the study. Overall, 41% of the patients (n = 22) experienced neuropathic pain during the VOC, mostly at an early stage (Day 2). The median age, the sex ratio, the location of the pain, and the morphine consumption were similar for patients with and without NP. Our study shows that neuropathic pain is very common during VOCs in SCD children. The absence of identified risk factors should prompt us to be vigilant regardless of the patient’s age, sex, and clinical presentation.

The Clinical Presentation of Pediatric Thoracolumbar Fractures: A Prospective Study

2008 ◽  
Vol 65 (5) ◽  
pp. 1066-1071 ◽  
Author(s):  
Edward P. Junkins ◽  
Alan Stotts ◽  
Rafael Santiago ◽  
Elisabeth Guenther
Keyword(s):  
Prospective Study ◽  
Clinical Presentation ◽  
Thoracolumbar Fractures ◽  
A Prospective Study

scholarly journals PWE-036 Clinical Presentation, Causes and Outcome of Ulcers in Ileo-Cecal Region: A Prospective Study from a Tropical Country

Gut ◽  
2013 ◽  
Vol 62 (Suppl 1) ◽  
pp. A145.1-A145
Author(s):  
J Toshniwal ◽  
R Chawlani ◽  
A Kumar ◽  
M Kumar ◽  
A Arora
Keyword(s):  
Prospective Study ◽  
Clinical Presentation ◽  
Tropical Country ◽  
A Prospective Study

The Correlation between Clinical Presentation of Cervical Spondylotic Myelopathy and MRI Findings in a Prospective Study of 278 Patients

2012 ◽  
Vol 12 (9) ◽  
pp. S35-S36
Author(s):  
Sukhvinder Kalsi-Ryan ◽  
Alina Karpova ◽  
Branko Kopjar ◽  
Eric M. Massicotte ◽  
Michael G. Fehlings
Keyword(s):  
Prospective Study ◽  
Cervical Spondylotic Myelopathy ◽  
Clinical Presentation ◽  
Mri Findings ◽  
A Prospective Study

scholarly journals Impact of Anti-Inflammatory Drugs on Pyogenic Vertebral Osteomyelitis: A Prospective Cohort Study

2016 ◽  
Vol 2016 ◽  
pp. 1-4
Author(s):  
Aurélien Dinh ◽  
Maxime Jean ◽  
Frédérique Bouchand ◽  
Benjamin Davido ◽  
Alexis Descatha ◽  
...  
Keyword(s):  
Clinical Presentation ◽  
Diagnostic Delay ◽  
Vertebral Osteomyelitis ◽  
Diagnosis Delay ◽  
Cure Rate ◽  
Pyogenic Vertebral Osteomyelitis ◽  
Inflammatory Drugs ◽  
Anti Inflammatory ◽  
A Prospective Study ◽  
The Impact

Objective. Pyogenic vertebral osteomyelitis (PVO) are frequently misdiagnosed and patients often receive anti-inflammatory drugs for their back pain. We studied the impact of these medications. Methods. We performed a prospective study enrolling patients with PVO and categorized them depending on their drugs intake. Then, we compared diagnosis delay, clinical presentation at hospitalization, incidence of complications, and cure rate. Results. In total, 79 patients were included. Multivariate analysis found no correlation between anti-inflammatory drug intake and diagnosis delay, clinical presentation, complications, or outcome. Conclusion. Anti-inflammatory drugs intake does not affect diagnostic delay, severity at diagnosis, or complications of PVO.

Sign in / Sign up

Export Citation Format

Share Document